Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions

Detalles Bibliográficos
Autores principales: Patoulias, Dimitrios, Papadopoulos, Christodoulos, Katsimardou, Alexandra, Toumpourleka, Maria, Doumas, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556544/
https://www.ncbi.nlm.nih.gov/pubmed/33052538
http://dx.doi.org/10.1007/s13300-020-00942-7
_version_ 1783594241157496832
author Patoulias, Dimitrios
Papadopoulos, Christodoulos
Katsimardou, Alexandra
Toumpourleka, Maria
Doumas, Michael
author_facet Patoulias, Dimitrios
Papadopoulos, Christodoulos
Katsimardou, Alexandra
Toumpourleka, Maria
Doumas, Michael
author_sort Patoulias, Dimitrios
collection PubMed
description
format Online
Article
Text
id pubmed-7556544
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-75565442020-10-15 Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions Patoulias, Dimitrios Papadopoulos, Christodoulos Katsimardou, Alexandra Toumpourleka, Maria Doumas, Michael Diabetes Ther Letter Springer Healthcare 2020-10-14 2020-12 /pmc/articles/PMC7556544/ /pubmed/33052538 http://dx.doi.org/10.1007/s13300-020-00942-7 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Letter
Patoulias, Dimitrios
Papadopoulos, Christodoulos
Katsimardou, Alexandra
Toumpourleka, Maria
Doumas, Michael
Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions
title Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions
title_full Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions
title_fullStr Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions
title_full_unstemmed Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions
title_short Sodium–Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions
title_sort sodium–glucose cotransporter 2 inhibitors and major covid-19 outcomes: promising mechanisms, conflicting data, and intriguing clinical decisions
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556544/
https://www.ncbi.nlm.nih.gov/pubmed/33052538
http://dx.doi.org/10.1007/s13300-020-00942-7
work_keys_str_mv AT patouliasdimitrios sodiumglucosecotransporter2inhibitorsandmajorcovid19outcomespromisingmechanismsconflictingdataandintriguingclinicaldecisions
AT papadopouloschristodoulos sodiumglucosecotransporter2inhibitorsandmajorcovid19outcomespromisingmechanismsconflictingdataandintriguingclinicaldecisions
AT katsimardoualexandra sodiumglucosecotransporter2inhibitorsandmajorcovid19outcomespromisingmechanismsconflictingdataandintriguingclinicaldecisions
AT toumpourlekamaria sodiumglucosecotransporter2inhibitorsandmajorcovid19outcomespromisingmechanismsconflictingdataandintriguingclinicaldecisions
AT doumasmichael sodiumglucosecotransporter2inhibitorsandmajorcovid19outcomespromisingmechanismsconflictingdataandintriguingclinicaldecisions

Ejemplares similares